The DOI matches its Crossref record; 102 of the 104 references it cites were found in a registry or an index.
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics
Open accessAbstract
Synaptic pathology and mitochondrial oxidative damage are early events in Alzheimer's disease (AD) progression. Loss of synapses and synaptic damage are the best correlates of cognitive deficits found in AD patients. Recent research on amyloid beta (Aβ) and mitochondria in AD revealed that Aβ accumulates in synapses and synaptic mitochondria, leading to abnormal mitochondrial dynamics and synaptic degeneration in AD neurons. Further, recent studies using live-cell imaging and primary neurons from amyloid beta precursor protein (AβPP) transgenic mice revealed reduced mitochondrial mass, defective axonal transport of mitochondria and synaptic degeneration, indicating that Aβ is responsible for mitochondrial and synaptic deficiencies. Tremendous progress has been made in studying antioxidant approaches in mouse models of AD and clinical trials of AD patients. This article highlights the recent developments made in Aβ-induced abnormal mitochondrial dynamics, defective mitochondrial biogenesis, impaired axonal transport and synaptic deficiencies in AD. This article also focuses on mitochondrial approaches in treating AD, and also discusses latest research on mitochondria-targeted antioxidants in AD. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, oxidative stress, mitochondrial dysfunction, and glucose hypometabolism have been well documented in MCI and AD brain [8,53,74,75,76].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As mentioned above, the use of redox proteomics has led to the identification of oxidized proteins, as indexed by carbonylation, nitration, and modification with HNE, in both in vitro and in vivo models of AD in addition to MCI and AD brain.”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence links neurodegeneration to altered brain metabolism and mitochondrial dysfunction, both of which are early hallmarks of AD [21–28].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consistent with the hypothesis that both oxidative stress and mitochondrial dysfunction are early events in the progression of AD [12,35,53], many of the oxidized proteins identified are mitochondrial proteins involved in metabolism, protein synthesis and folding, ROS scavenging, transport, and apoptosis (Table 1).”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The presence of Aβ oligomers in mitochondrial membranes is consistent with Aβ-induced mitochondrial dysfunction occurring early in the disease progression timeline [34,53].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,740
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224
Flagged first, then by citations
2 of the 104 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 395
Park, J., Choi, H., Min, J., Kim, B., Lee, S., Yun, J. W., Choi, M., Chang, K., & Lee, D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.12984 · Cited by 93
The optic nerve: A “mito-window” on mitochondrial neurodegeneration
Maresca, A., Morgia, C. L., Caporali, L., Valentino, M. L., & Carelli, V. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.004 · Cited by 97
Islam, F., Nafady, M. H., Islam, M. R., Saha, S., Rashid, S., Akter, A., Harun-Or-Rashid, M., Akhtar, M. F., Perveen, A., Ashraf, G. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02859-7 · Cited by 95
Wong, H., Levenga, J., Cain, P., Rothermel, B. A., Klann, E., & Hoeffer, C. A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1499-8 · Cited by 91
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 89
Self-citationMitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85
“Consistent with the hypothesis that both oxidative stress and mitochondrial dysfunction are early events in the progression of AD [12,35,53], many of the oxidized”
BackgroundMańczak, M., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130275 · Cited by 90
Self-citationIs the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 88
Self-citationTribble, J. R., Vasalauskaite, A., Redmond, T., Young, R. D., Hassan, S., Fautsch, M. P., Sengpiel, F., Williams, P. A., & Morgan, J. E. (2019) · Brain Communications · doi:10.1093/braincomms/fcz035 · Cited by 86
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 93
Du, F., Wang, Y., Zhang, Z., Du, H., Yan, S., Sun, Q., Zhong, C., Wu, L., Vangavaragu, J. R., Yan, S., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv241 · Cited by 86
AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons
Amadoro, G., Corsetti, V., Florenzano, F., Atlante, A., Ciotti, M. T., Mongiardi, M. P., Bussani, R., Nicolin, V., Nori, S. L., Campanella, M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.018 · Cited by 86
Mansur, A., Rabiner, E. A., Comley, R. A., Lewis, Y. L., Middleton, L. T., Huiban, M., Passchier, J., Tsukada, H., & Gunn, R. N. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.228080 · Cited by 85
Zhang, W., Gu, G.-J., Shen, X., Zhang, Q., Wang, G., & Wang, P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.040 · Cited by 85
Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective
Kodavati, M. M., Wang, H., & Hegde, M. L. (2020) · Cells · doi:10.3390/cells9041065 · Cited by 87
Kondadi, A. K., Wang, S., Montagner, S., Kladt, N., Korwitz, A., Martinelli, P., Herholz, D., Baker, M. J., Schauss, A. C., Langer, T., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201387009 · Cited by 83
Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders
Yang, S., He, X., Isaacs, C. E., Dobkin, C., Miller, D. L., & Philipp, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.001 · Cited by 85
Journal of Parkinson’s disease & Alzheimer’s disease
Gottschalk, W. K., Lutz, M. W., He, Y. T., Saunders, A. M., Burns, D. K., Roses, A. D., & Chiba‐Falek, O. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000003 · Cited by 80
Kumar, S., Morton, H., Sawant, N., Orlov, E., Bunquin, L. E., Pradeepkiran, J. A., Alvir, R., & Reddy, P. H. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102182 · Cited by 75
Self-citationKshirsagar, S., Sawant, N. A., Morton, H., Reddy, A. P., & Reddy, P. H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105973 · Cited by 76
Self-citationRetractedCytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Arnold, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_13 · Cited by 77
The role of synaptic microRNAs in Alzheimer's disease
Kumar, S., & Reddy, P. H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165937 · Cited by 73
Self-citationThe Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS
Dafinca, R., Barbagallo, P., & Talbot, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.653688 · Cited by 73
Calkins, M. J., Mańczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 71
Self-citationHill, R. L., Kulbe, J. R., Singh, I. N., Wang, J. A., & Hall, E. D. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.028 · Cited by 75
Wang, D., Yan, J., Chen, J., Wu, W., Zhu, X., & Wang, Y. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0201-y · Cited by 76
Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00308-y · Cited by 80
Kasote, D. M., Hegde, M. V., & Katyare, S. S. (2013) · BioFactors · doi:10.1002/biof.1093 · Cited by 73
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 75
Ahmadi, N., Safari, S., Mirazi, N., Karimi, S. A., & Komaki, A. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.024 · Cited by 71
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Mańczak, M., Sheiko, T. V., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130761 · Cited by 73
Self-citationKuruva, C. S., Mańczak, M., Yin, X., Ogunmokun, G., Reddy, A. P., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx226 · Cited by 71
Self-citationRetractedPark, J., Choi, H., Kim, B., Chae, U., Lee, D. G., Lee, S.-R., Lee, S., Lee, H., & Lee, D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.08.030 · Cited by 71
Stem cell therapies in age-related neurodegenerative diseases and stroke
Wang, Y., Ji, X., Leak, R. K., Chen, F., & Cao, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.002 · Cited by 74
Sotolongo, K., Ghiso, J. A., & Rostagno, A. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0578-9 · Cited by 74
Panes-Fernández, J., Godoy, P. A., Silva-Grecchi, T., Celis, M. T., Ramírez-Molina, O., Gavilán, J., Muñoz-Montesino, C., Castro, P. A., Moraga‐Cid, G., Yévenes, G. E., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00709 · Cited by 71
Kshirsagar, S., Sawant, N. A., Morton, H., Reddy, A. P., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab262 · Cited by 68
Self-citationRetractedMitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Lin, H., Magrané, J., Rattelle, A., Степанова, А., Galkin, A. S., Clark, E. M., Dong, Y., Halawani, S. M., & Lynch, D. R. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030502 · Cited by 68
Song, J., & Kim, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00227 · Cited by 66
A New Discovery of MicroRNA-455-3p in Alzheimer’s Disease
Kumar, S., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190583 · Cited by 67
Self-citationApolipoprotein D in Oxidative Stress and Inflammation
Fyfe-Desmarais, G., Desmarais, F., Rassart, É., & Mounier, C. (2023) · Antioxidants · doi:10.3390/antiox12051027 · Cited by 70
Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
Cardoso, S., Carvalho, C., Correia, S. C., Seiça, R. M. F., & Moreira, P. I. (2016) · Brain Pathology · doi:10.1111/bpa.12402 · Cited by 69
In vivo axonal transport deficits in a mouse model of fronto-temporal dementia
Majid, T., Ali, Y., Venkitaramani, D. V., Jang, M., Lu, H., & Pautler, R. G. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.02.005 · Cited by 69
Gan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Swerdlow, R. H., Chen, J. X., & Yan, S. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.021 · Cited by 62
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Samanta, S., Akhter, F., Roy, A., Chen, D., Turner, B., Wang, Y., Clemente, N., Wang, C., Swerdlow, R. H., Battaile, K. P., et al. (2023) · Brain · doi:10.1093/brain/awad432 · Cited by 62
The meaning of mitochondrial movement to a neuron's life
Lovas, J. R., & Wang, X. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.007 · Cited by 66
Foret, M. K., Orciani, C., Welikovitch, L. A., Huang, C., Cuello, A. C., & Carmo, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-06552-4 · Cited by 63
Xu, Y., Mei, Y., Shi, X.-Q., Yi-fang, Z., Wang, X., Guan, L., Wang, Q., & Pan, H. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.037 · Cited by 61
Bhatti, J. S., Kumar, S., Vijayan, M., Bhatti, G. K., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.012 · Cited by 61
Self-citationYang, L., Li, D., Zhang, L., Bai, J., Chen, F., & Luo, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02569 · Cited by 60
Dixit, S., Fessel, J. P., & Harrison, F. E. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.021 · Cited by 57
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Irwin, M. H., Moos, W. H., Faller, D. V., Steliou, K., & Pinkert, C. A. (2016) · Drug Development Research · doi:10.1002/ddr.21294 · Cited by 57
Vion, E., Page, G., Bourdeaud, E., Paccalin, M., Guillard, J., & Bilan, A. R. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.12.003 · Cited by 56
Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement
Wang, Q., Tian, J., Chen, H., Du, H., & Guo, L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.021 · Cited by 56
Siddappaji, K. K., & Gopal, S. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021020 · Cited by 58
Reddy, A. P., Sawant, N. A., Morton, H., Kshirsagar, S., Bunquin, L. E., Yin, X., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab091 · Cited by 55
Self-citationOxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects
Wojsiat, J., Prandelli, C., Laskowska-Kaszub, K., Martín‐Requero, Á., & Wojda, U. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141977 · Cited by 58
Jurcău, A. (2021) · Nutrients · doi:10.3390/nu13020282 · Cited by 54
Kandimalla, R. J. L., Mańczak, M., Pradeepkiran, J. A., Morton, H., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab360 · Cited by 54
Self-citationRetractedWang, Y., Zhou, Y., Jiang, L. H., Wang, S., Zhu, L., Zhang, S., Yang, H., He, Q., Liu, L., Xie, Y., et al. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114371 · Cited by 56
George, E., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190232 · Cited by 55
Self-citationA Critical Assessment of Research on Neurotransmitters in Alzheimer’s Disease
Reddy, P. H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170256 · Cited by 52
Self-citationFlorenzano, F., Corsetti, V., Ciasca, G., Ciotti, M. T., Pittaluga, A., Olivero, G., Feligioni, M., Iannuzzi, F., Latina, V., Sciacca, M. F. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17371 · Cited by 54
Bi, R., Zhang, W., Zhang, D., Xu, M., Fan, Y., Hu, Q.-X., Jiang, H., Tan, L., Li, T., Fang, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0144-3 · Cited by 54
Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss
Zhao, C., Su, P., Lv, C., Guo, L., Cao, G., Qin, C., & Zhang, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7593608 · Cited by 54
Mitochondria in Aging and Alzheimer’s Disease: Focus on Mitophagy
Pradeepkiran, J. A., Baig, J., Seman, A., & Reddy, P. H. (2023) · The Neuroscientist · doi:10.1177/10738584221139761 · Cited by 52
Self-citationYu, Q., Du, F., Douglas, J. T., Yu, H., Yan, S. S., & Yan, S. F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170283 · Cited by 51
Xu, Y., Mei, Y., Qu, Z.-L., Zhang, S., Zhao, W., Fang, J., Wu, J., Yang, C., Liu, S., Fang, Y., et al. (2018) · BioMed Research International · doi:10.1155/2018/4606752 · Cited by 50
Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
Comerota, M. M., Krishnan, B., & Taglialatela, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-15357-x · Cited by 49
The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
Yin, X., Qiu, Y., Zhao, C., Zhou, Z., Bao, J., & Qian, W. (2021) · Medical Science Monitor · doi:10.12659/msm.933084 · Cited by 48
Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
Schaffer, C., Sarad, N., DeCrumpe, A., Goswami, D., Herrmann, S., Morales, J., Patel, P., & Osborne, J. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068214559979 · Cited by 50
Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 48
Zhang, L., Trushin, S., Christensen, T. A., Tripathi, U., Hong, C. C., Geroux, R. E., Howell, K. G., Poduslo, J. F., & Trushina, E. V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.003 · Cited by 50
Zafeer, M. F., Firdaus, F., Anis, E., & Hossain, M. S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.04.006 · Cited by 48
Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Cavallucci, V., Ferraina, C., & D’Amelio, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360005 · Cited by 47
Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
Kumar, S., Orlov, E., Gowda, P., Bose, C., Swerdlow, R. H., Lahiri, D. K., & Reddy, P. H. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00319-8 · Cited by 46
Self-citationAMPK: Potential Therapeutic Target for Alzheimer's Disease
Yang, L., Jiang, Y., Shi, L., Zhong, D., Li, Y., Li, J., & Jin, R. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190819142746 · Cited by 48
Kshirsagar, S., Alvir, R. V., Pradeepkiran, J. A., Hindle, A., Vijayan, M., Ramasubramaniam, B., Kumar, S., Reddy, A. P., & Reddy, P. H. (2022) · Cells · doi:10.3390/cells11172660 · Cited by 47
Self-citationRetractedVerma, H., Gangwar, P., Yadav, A., Yadav, B., Rao, R., Kaur, S., Kumar, P., Dhiman, M., Taglialatela, G., & Mantha, A. K. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.09.003 · Cited by 46
Wuwongse, S., Cheng, S. S., Wong, G. T.-H., Hung, C. H.-L., Zhang, N. Q., Ho, J. Y. S., Law, A. C.-K., & Chang, R. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.022 · Cited by 45
Nootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease
Vyas, S., Kothari, S. L., & Kachhwaha, S. (2019) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2019.100291 · Cited by 48
Effects of treadmill exercise on mitochondrial fusion and fission in the hippocampus of APP/PS1 mice
Yan, Q.-W., Zhao, N., Xia, J., Li, B., & Yin, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.030 · Cited by 44
Sinha, J. K., Jorwal, K., Singh, D. K. K., Han, S. S., Bhaskar, R., & Ghosh, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04474-0 · Cited by 46
Amadoro, G., Latina, V., Corsetti, V., & Calissano, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165584 · Cited by 44
Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
Luo, Y., Li, D., Liao, Y., Cai, C., Wu, Q., Ke, H., Liu, X., Li, H.-L., Hong, H., Xu, Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00381 · Cited by 43
Mańczak, M., & Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.008 · Cited by 41
Self-citationMahley, R. W. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102684 · Cited by 43
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics
Flannery, P. J., & Trushina, E. V. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00179-0 · Cited by 41
Zhao, C., Lv, C., Li, H., Du, S., Liu, X., Li, Z., Xin, W., & Zhang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152551 · Cited by 39
Vijayan, M., Alvir, R. V., Alvir, R. V., Bunquin, L. E., Pradeepkiran, J. A., & Reddy, P. H. (2022) · Aging Cell · doi:10.1111/acel.13663 · Cited by 40
Self-citationBandaru, L. J. M., Ayyalasomayajula, N., Murumulla, L., & Challa, S. (2022) · BioMetals · doi:10.1007/s10534-021-00360-7 · Cited by 39
Skawratananond, S., Xiong, D. X., Zhang, C., Tonk, S. S., Pinili, A., Delacruz, B., Pham, P., Smith, S. C., Navab, R., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102732 · Cited by 41
Self-citationEhinger, Y., Bruyère, J., Panayotis, N., Abada, Y.-S. K., Borloz, E., Matagne, V., Scaramuzzino, C., Vitet, H., Delatour, B., Saidi, L., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910889 · Cited by 39
Maqoud, F., Scala, R., Hoxha, M., Zappacosta, B., & Tricarico, D. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210119095626 · Cited by 39
Mota, S. I., Ferreira, I. L., Valero, J., Ferreiro, E. B., Carvalho, A. L., Oliveira, C. R., & Rego, A. C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.023 · Cited by 38
Zweig, J. A., Brandes, M. S., Brumbach, B. H., Caruso, M. A., Wright, K. M., Quinn, J. F., Soumyanath, A., & Gray, N. E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.11.019 · Cited by 35
Singh, N., Nandy, S. K., Jyoti, A., Saxena, J., Sharma, A., Siddiqui, A. J., & Sharma, L. K. (2024) · Brain Sciences · doi:10.3390/brainsci14060554 · Cited by 35
Ji, X., Chi, T., Xu, Q., He, X., Xiao-yu, Z., Zhang, R., & Zou, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/969342 · Cited by 34
Metadata
- Authors
- Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., & Manczak, M.
- Affiliations
- Oregon National Primate Research Center (US)
- Corresponding author
- Reddy, P. Hemachandra
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 1822
- Issue
- 5
- Pages
- 639-649
- ISSN
- 0925-4439 (ISSN-L)
- PMC
- PMC3272314
- OpenAlex
- W1996981671
- Cited by
- 394
- References
- 104
- Citations by year
- 2026: 29 · 2025: 17 · 2024: 22 · 2023: 27 · 2022: 30 · 2021: 38 · 2020: 29 · 2019: 30 · 2018: 26 · 2017: 36 · 2016: 31 · 2015: 19 · 2014: 31 · 2013: 18 · 2012: 10
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH
- Alzheimer Association
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, mitochondrial dynamics, synaptic degeneration, amyloid-beta, mitochondrial oxidative damage, mitochondrial biogenesis, mitochondria-targeted antioxidants, antioxidant therapeutics, synaptic mitochondria
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Humans, Mice, Transgenic, Mitochondria, Synapses, Amyloid beta-Protein Precursor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
